Urgent.News

600+ sources. One page. See who else covered it.

Editions

Business

Dax aktuell: „Fast ein Goldlöckchen-Szenario“: Dax notiert im Plus knapp unter Rekord – SAP setzt Rally fort

Der Dax kann an seine kürzliche Rekordrally anschließen und festigt sich über der Marke von 26.000 Punkten. Konjunkturzahlen könnten einen positiven Ausblick liefern.

Original German Read in English

Dax aktuell: „Fast ein Goldlöckchen-Szenario“: Dax notiert im Plus knapp unter Rekord – SAP setzt Rally fort

The DAX continues to defy concerns that recent gains could be used for dividend harvesting. On the last trading day of the week, the index closed 0.6 percent higher at 26,459 points. It had remained unchanged on Thursday after reaching a new record of 26,573.50 points on Wednesday. The German benchmark index is distancing itself from geopolitical events in the Middle East, which dominated the first half of the year.

Strong quarterly results and growth prospects have been driving the rally in the German equity market. According to Andreas Lipkow, Chief Market Analyst at CMC Markets, investors might be close to a "Goldilocks scenario," meaning a healthy economy with steady growth, low inflation, and low interest rates. However, geopolitical risks persist with the conflict in the Middle East.

Kyle Rodda, Senior Financial Market Analyst at capital.com, warns that the clash between economic growth and geopolitical factors remains the main macroeconomic hurdle for a market benefiting from the reporting season and central bank outlook.

Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at handelsblatt.com →

More in Business

SK Bioscience Seeks Global RSV Antibody Trial

SK Bioscience is expanding its research and development scope in earnest beyond vaccines to antibody-based preventive medicines.SK Bioscience announced on August 14 that it submitted a clinical trial…

  • SK Bioscience submits Phase 1b trial application for RSV preventive antibody RSM01.
  • Trial to involve 80 infants aged 2 weeks to 8 months, regulated by SAHPRA.
  • RSV causes severe infections in infants with immature immune systems.

Hanwha Aerospace Starts Trajectory Fuze Development

Hanwha Aerospace announced on August 14 that it has been selected as the preferred bidder for the ‘Trajectory Correctable Fuze System Development Project’ supervised by the Defense Acquisition Program…

  • Hanwha Aerospace selected for Trajectory Correctable Fuze project on August 14
  • Fuze aims to increase 155mm ammunition accuracy by adjusting flight path
  • System development planned to complete by 2032 for K9 self-propelled howitzer

More from Friday 14 August →